154 related articles for article (PubMed ID: 31309749)
1. [Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis].
Zhang L; Yang H; Zhang X; Chen Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 48(2):130-135. PubMed ID: 31309749
[TBL] [Abstract][Full Text] [Related]
2. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
[TBL] [Abstract][Full Text] [Related]
3. [The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis].
Lou J; Huang X; Zhang L; Xu P; Zhang X; Chen Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 48(2):136-141. PubMed ID: 31309750
[TBL] [Abstract][Full Text] [Related]
4. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
5. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
6. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
[TBL] [Abstract][Full Text] [Related]
7. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
[TBL] [Abstract][Full Text] [Related]
8. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of levonorgestrel intrauterine system (Mirena) combined with hysteroscopy in the treatment of perimenopausal AUB patients.
Sun Y; Qian M; Hu D
Pak J Pharm Sci; 2021 Sep; 34(5(Special)):2079-2083. PubMed ID: 34862877
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of adenomyomectomy using "H" type incision combined with Mirena in the treatment of adenomyosis.
Gao Y; Shan S; Zhao X; Jiang J; Li D; Shi B
Medicine (Baltimore); 2019 Mar; 98(11):e14579. PubMed ID: 30882624
[TBL] [Abstract][Full Text] [Related]
11. Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial.
Mawet M; Nollevaux F; Nizet D; Wijzen F; Gordenne V; Tasev N; Segedi D; Marinescu B; Enache A; Parhomenko V; Frankenne F; Foidart JM
Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):169-79. PubMed ID: 24666176
[TBL] [Abstract][Full Text] [Related]
12. Insertion of the Mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method.
Peng FS; Wu MY; Yang JH; Chen SU; Ho HN; Yang YS
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):160-4. PubMed ID: 20708521
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis.
Song SY; Lee SY; Kim HY; Park DB; Kim DE; Lee KH; Lee S; Yang JB; Yoo HJ
Medicine (Baltimore); 2020 May; 99(22):e20421. PubMed ID: 32481439
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
Beelen P; van den Brink MJ; Herman MC; Geomini PMAJ; Dekker JH; Duijnhoven RG; Mak N; van Meurs HS; Coppus SF; van der Steeg JW; Eising HP; Massop-Helmink DS; Klinkert ER; Nieboer TE; Timmermans A; van der Voet LF; Veersema S; Smeets NAC; Schutte JM; van Baal M; Bossuyt PM; Mol BWJ; Berger MY; Bongers MY
Am J Obstet Gynecol; 2021 Feb; 224(2):187.e1-187.e10. PubMed ID: 32795428
[TBL] [Abstract][Full Text] [Related]
15. The suture fixation of levonorgestrel-releasing intrauterine device using the hysteroscopic cold-knife surgery system: an original method in treatment of adenomyosis.
Zhu L; Yang X; Cao B; Tang S; Tong J
Fertil Steril; 2021 Oct; 116(4):1191-1193. PubMed ID: 34238576
[TBL] [Abstract][Full Text] [Related]
16. Insertion of mirena after endometrial resection in patients with adenomyosis.
Maia H; Maltez A; Coelho G; Athayde C; Coutinho EM
J Am Assoc Gynecol Laparosc; 2003 Nov; 10(4):512-6. PubMed ID: 14738640
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study.
Chen S; Wang J; Sun W; Zhu L; He J; Zhang X
Ann Transl Med; 2020 Nov; 8(21):1356. PubMed ID: 33313101
[TBL] [Abstract][Full Text] [Related]
19. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
Rose S; Chaudhari A; Peterson CM
Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
[TBL] [Abstract][Full Text] [Related]
20. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.
Gemzell-Danielsson K; Schellschmidt I; Apter D
Fertil Steril; 2012 Mar; 97(3):616-22.e1-3. PubMed ID: 22222193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
